Ma, J., Li, X., Zhang, Q., Li, N., Sun, S., Zhao, S., . . . Li, M. (2022). A novel treatment strategy of HER2-targeted therapy in combination with Everolimus for HR+/HER2- advanced breast cancer patients with HER2 mutations. Translational Oncology, 21(101444-), . https://doi.org/10.1016/j.tranon.2022.101444
Chicago-referens (17:e uppl.)Ma, Jing, Xuelu Li, Qianran Zhang, Ning Li, Siwen Sun, Shanshan Zhao, Zuowei Zhao, och Man Li. "A Novel Treatment Strategy of HER2-targeted Therapy in Combination with Everolimus for HR+/HER2- Advanced Breast Cancer Patients with HER2 Mutations." Translational Oncology 21, no. 101444- (2022). https://doi.org/10.1016/j.tranon.2022.101444.
MLA-referens (9:e uppl.)Ma, Jing, et al. "A Novel Treatment Strategy of HER2-targeted Therapy in Combination with Everolimus for HR+/HER2- Advanced Breast Cancer Patients with HER2 Mutations." Translational Oncology, vol. 21, no. 101444-, 2022, https://doi.org/10.1016/j.tranon.2022.101444.
